Pieris Pharmaceuticals Inc (PIRS)
15.93
-0.08
(-0.47%)
USD |
NASDAQ |
Nov 21, 16:00
15.93
0.00 (0.00%)
After-Hours: 20:00
Pieris Pharmaceuticals Price to Book Value: 1.293 for Nov. 21, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 21, 2024 | 1.293 |
| November 20, 2024 | 1.299 |
| November 19, 2024 | 1.265 |
| November 18, 2024 | 1.253 |
| November 15, 2024 | 1.288 |
| November 14, 2024 | 1.294 |
| November 13, 2024 | 1.307 |
| November 12, 2024 | 1.308 |
| November 11, 2024 | 1.296 |
| November 08, 2024 | 1.370 |
| November 07, 2024 | 1.342 |
| November 06, 2024 | 1.360 |
| November 05, 2024 | 1.384 |
| November 04, 2024 | 1.382 |
| November 01, 2024 | 1.408 |
| October 31, 2024 | 1.400 |
| October 30, 2024 | 1.369 |
| October 29, 2024 | 1.380 |
| October 28, 2024 | 1.380 |
| October 25, 2024 | 1.375 |
| October 24, 2024 | 1.380 |
| October 23, 2024 | 1.376 |
| October 22, 2024 | 1.333 |
| October 21, 2024 | 1.363 |
| October 18, 2024 | 1.373 |
| Date | Value |
|---|---|
| October 17, 2024 | 1.374 |
| October 16, 2024 | 1.338 |
| October 15, 2024 | 1.319 |
| October 14, 2024 | 1.320 |
| October 11, 2024 | 1.343 |
| October 10, 2024 | 1.327 |
| October 09, 2024 | 1.312 |
| October 08, 2024 | 1.302 |
| October 07, 2024 | 1.313 |
| October 04, 2024 | 1.320 |
| October 03, 2024 | 1.322 |
| October 02, 2024 | 1.343 |
| October 01, 2024 | 1.348 |
| September 30, 2024 | 1.346 |
| September 27, 2024 | 1.141 |
| September 26, 2024 | 1.141 |
| September 25, 2024 | 1.164 |
| September 24, 2024 | 1.205 |
| September 23, 2024 | 1.214 |
| September 20, 2024 | 1.217 |
| September 19, 2024 | 1.199 |
| September 18, 2024 | 1.141 |
| September 17, 2024 | 1.169 |
| September 16, 2024 | 1.172 |
| September 13, 2024 | 1.177 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.404
Minimum
Jun 30 2023
11.00
Maximum
Dec 02 2019
3.131
Average
3.180
Median
Price to Book Value Benchmarks
| Ligand Pharmaceuticals Inc | 2.618 |
| NovaBay Pharmaceuticals Inc | 3.299 |
| Palatin Technologies Inc | -- |
| iBio Inc | 1.263 |
| Theriva Biologics Inc | 0.1446 |
Price to Book Value Related Metrics
| PS Ratio | 0.4956 |
| Price | 15.93 |
| Earnings Yield | -76.38% |
| Market Cap | 21.04M |